Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinics in Chest Medicine|August 21, 2018
Venous Thromboembolism in Special Populations: Preexisting Cardiopulmonary Disease, Cirrhosis, End-Stage Renal Disease, and AspleniaQuyen Nguyen, Belinda N Rivera-Lebron
Therapeutic Advances in Respiratory Disease|April 21, 2017
Ambrisentan: a review of its use in pulmonary arterial hypertensionBelinda N Rivera-Lebron, Michael G Risbano
Chest|August 8, 2020
The PERT Concept: A Step-by-Step Approach to Managing Pulmonary EmbolismBelinda N Rivera-Lebron, Parth M Rali, Victor F Tapson
Journal of Clinical Medicine|January 28, 2026
Post-Pulmonary Embolism Syndrome: New Phenotypes Come into FocusBilal H Lashari, Stephen Dachert, Belinda N Rivera-Lebron, et al.
Pulmonary Circulation|April 15, 2016
Determinants of 6-minute walk distance in patients with idiopathic pulmonary fibrosis undergoing lung transplant evaluationMary K Porteous, Belinda N Rivera-Lebron, Maryl Kreider, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 21, 2018
Pulmonary Embolism Response Teams: A Novel Approach for the Care of Complex Patients With Pulmonary EmbolismMateo Porres-Aguilar, Javier E Anaya-Ayala, Gustavo A Heresi, et al.
Journal of Thrombosis and Thrombolysis|April 9, 2021
Direct oral anticoagulants in chronic thromboembolic pulmonary hypertensionMateo Porres-Aguilar, Marius M Hoeper, Belinda N Rivera-Lebron, et al.
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|November 5, 2020
Perioperative Acute Pulmonary Embolism: A Concise Review with Emphasis on Multidisciplinary ApproachMateo Porres-Aguilar, Belinda N Rivera-Lebron, Javier E Anaya-Ayala, et al.
Chest|March 2, 2013
Echocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosisBelinda N Rivera-Lebron, Paul R Forfia, Maryl Kreider, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 20, 2018
Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed ThrombolysisLara M Groetzinger, Taylor J Miller, Ryan M Rivosecchi, et al.
Pageof 2